BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31348124)

  • 1. Five-year Impact of a Commercial Accountable Care Organization on Health Care Spending, Utilization, and Quality of Care.
    Zhang H; Cowling DW; Graham JM; Taylor E
    Med Care; 2019 Nov; 57(11):845-854. PubMed ID: 31348124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a commercial accountable care organization on prescription drugs.
    Zhang H; Cowling DW; Graham JM; Taylor E
    Health Serv Res; 2021 Aug; 56(4):592-603. PubMed ID: 33508877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Specialist Office Visits and Health Expenditures in Accountable Care Organizations.
    Shetty VA; Balzer LB; Geissler KH; Chin DL
    JAMA Netw Open; 2019 Jul; 2(7):e196796. PubMed ID: 31290989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Pioneer Accountable Care Organizations vs traditional Medicare fee for service with spending, utilization, and patient experience.
    Nyweide DJ; Lee W; Cuerdon TT; Pham HH; Cox M; Rajkumar R; Conway PH
    JAMA; 2015 Jun; 313(21):2152-61. PubMed ID: 25938875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract.
    McWilliams JM; Landon BE; Chernew ME
    JAMA; 2013 Aug; 310(8):829-36. PubMed ID: 23982369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchmarking Implications: Analysis of Medicare Accountable Care Organizations Spending Level and Quality of Care.
    Hong YR; Kates F; Song SJ; Lee N; Duncan RP; Marlow NM
    J Healthc Qual; 2018; 40(6):344-353. PubMed ID: 29474312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spending outcomes among patients with cancer in accountable care organizations 4 years after implementation.
    Erfani P; Phelan J; Orav EJ; Figueroa JF; Jha AK; Lam MB
    Cancer; 2022 Mar; 128(5):1093-1100. PubMed ID: 34767638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Performance of Accountable Care Organizations in Medicare.
    McWilliams JM; Hatfield LA; Chernew ME; Landon BE; Schwartz AL
    N Engl J Med; 2016 Jun; 374(24):2357-66. PubMed ID: 27075832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spending Among Patients With Cancer in the First 2 Years of Accountable Care Organization Participation.
    Lam MB; Figueroa JF; Zheng J; Orav EJ; Jha AK
    J Clin Oncol; 2018 Oct; 36(29):2955-2960. PubMed ID: 30156985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Participation in Medicare Accountable Care Organizations and Spillovers in Commercial Spending.
    Post B; Ryan AM; Moloci NM; Li J; Dupree JM; Hollingsworth JM
    Med Care; 2019 Apr; 57(4):305-311. PubMed ID: 30789539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACO Spending and Utilization Among Medicare Patients at the End of Life: an Observational Study.
    Lam MB; Friend TH; Erfani P; Orav EJ; Jha AK; Figueroa JF
    J Gen Intern Med; 2022 Oct; 37(13):3275-3282. PubMed ID: 35022958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program.
    Schwartz AL; Chernew ME; Landon BE; McWilliams JM
    JAMA Intern Med; 2015 Nov; 175(11):1815-25. PubMed ID: 26390323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient care patterns and organizational accountability in Medicare.
    McWilliams JM; Chernew ME; Dalton JB; Landon BE
    JAMA Intern Med; 2014 Jun; 174(6):938-45. PubMed ID: 24756690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between specialist compensation and Accountable Care Organization performance.
    Ganguli I; Lupo C; Mainor AJ; Orav EJ; Blanchfield BB; Lewis VA; Colla CH
    Health Serv Res; 2020 Oct; 55(5):722-728. PubMed ID: 32715464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pharmacy services in accountable care organizations.
    Colla CH; Lewis VA; Beaulieu-Jones BR; Morden NE
    J Manag Care Spec Pharm; 2015 Apr; 21(4):338-44. PubMed ID: 25803767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Accountable Care Organizations of Diverse Structures Achieve Comparable Quality and Cost Performance.
    Comfort LN; Shortell SM; Rodriguez HP; Colla CH
    Health Serv Res; 2018 Aug; 53(4):2303-2323. PubMed ID: 29388199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization by Long-Term Nursing Home Residents Under Accountable Care Organizations.
    Chang CH; Mainor A; Colla C; Bynum J
    J Am Med Dir Assoc; 2021 Feb; 22(2):406-412. PubMed ID: 32693998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Effects of Pioneer Accountable Care Organizations on Medicare Part D Drug Spending and Utilization.
    Zhang Y; Caines KJ; Powers CA
    Med Care; 2017 May; 55(5):470-475. PubMed ID: 28060052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery system performance as financial risk varies.
    Newhouse JP; Price M; Hsu J; Landon B; McWilliams JM
    Am J Manag Care; 2019 Dec; 25(12):e388-e394. PubMed ID: 31860233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance in the Medicare Shared Savings Program by Accountable Care Organizations Disproportionately Serving Dual and Disabled Populations.
    Sen AP; Chen LM; Wong Samson L; Epstein AM; Joynt Maddox KE
    Med Care; 2018 Sep; 56(9):805-811. PubMed ID: 30036235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.